Dr. David Kuhn, a SIRF-sponsored researcher at Virginia Tech, provides a detailed look into his antibody fish farming research.  Outlining the methods of his study, Dr. Kuhn hopes the project will lead to developments preventing large-scale disease outbreaks and economic loss within the aquaculture industry.  As the first study of its kind performed on fish, the project’s success will be gaged by the antibody’s ability to protect fish from infection. Next research steps include determining dosage, economic feasibility of antibody treatment and a testing of other fish species.